Gansu, Sichuan, China | Fund Name | Location |
| ABC International | China, Hong Kong, Hong Kong Island |
| aCommerce | Bangkok, Krung Thep, Thailand |
| Anchors Capital | China, Guangdong, Shenzhen |
| Black Ice Capital | - |
| Chuangke 100 Venture Capital Fund | Beijing, Changping, China |
| Crush Ventures | California, Los Angeles, United States |
| District Ventures Capital | Alberta, Calgary, Canada |
| Earth Space Robotics | - |
| First Capital | China, Futian, Guangdong |
| Franklin Park | Bala Cynwyd, Pennsylvania, United States |
| Holt Family Investments | Georgia, Rome, United States |
| Honghe Erhao | - |
| KEB Hana Bank | Seoul, Seoul-t'ukpyolsi, South Korea |
| Palace Group | - |
| PHOENIX group | Baden-Wurttemberg, Germany, Mannheim |
| Reinforced Ventures | Pennsylvania, Pittsburgh, United States |
| SciFi VC | California, San Francisco, United States |
| Serengeti Capital | Accra, Ghana, Greater Accra Region |
| Shanghai Langyi International Trade | China, Huangpu, Shanghai |
| Shenzhen Lietou Fund | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Clover Biopharmaceuticals | $9M | 14 Dec 2017 | Sichuan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Clover Biopharmaceuticals | $9M | 14 Dec 2017 | Sichuan |
